Status:
ACTIVE_NOT_RECRUITING
Reversal of Neuromuscular Blockade During the General Anaesthesia
Lead Sponsor:
Tampere University Hospital
Conditions:
Neuromuscular Blockade
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
There are individual reports indicating that after the reversal of nondepolarizing neuromuscular blockade with neostigmine, some patients starts to relax spontaneously again after the tof ratio has al...
Detailed Description
There are individual reports indicating that after the reversal of nondepolarizing neuromuscular blockade with neostigmine, some patients start to relax spontaneously again after the tof ratio has alr...
Eligibility Criteria
Inclusion
- Elective surgery requiring general anaesthesia
- Surgery is assumed to last more than 45 minutes
- Body mass index less than 35kg/ m²
Exclusion
- Disease of central nervous system
- Trauma of central nervous system
- Disease affecting peripheral nervous system
- Medication affecting peripheral nervous system
Key Trial Info
Start Date :
April 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04048655
Start Date
April 8 2020
End Date
December 31 2025
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital
Tampere, Finland, 33520